223 related articles for article (PubMed ID: 11803101)
1. Endometrial disorders in 406 breast cancer patients on tamoxifen: the case for less intensive monitoring.
Vosse M; Renard F; Coibion M; Neven P; Nogaret JM; Hertens D
Eur J Obstet Gynecol Reprod Biol; 2002 Feb; 101(1):58-63. PubMed ID: 11803101
[TBL] [Abstract][Full Text] [Related]
2. Risk Factors Associated with Endometrial Pathology in Premenopausal Breast Cancer Patients Treated with Tamoxifen.
Lee M; Piao J; Jeon MJ
Yonsei Med J; 2020 Apr; 61(4):317-322. PubMed ID: 32233174
[TBL] [Abstract][Full Text] [Related]
3. Effects of adjuvant tamoxifen on the endometrium in postmenopausal women with breast cancer: a prospective long-term study using transvaginal ultrasound.
Gerber B; Krause A; Müller H; Reimer T; Külz T; Makovitzky J; Kundt G; Friese K
J Clin Oncol; 2000 Oct; 18(20):3464-70. PubMed ID: 11032586
[TBL] [Abstract][Full Text] [Related]
4. Sonohysterography compared with endometrial biopsy for evaluation of the endometrium in tamoxifen-treated women.
Hann LE; Kim CM; Gonen M; Barakat R; Choi PH; Bach AM
J Ultrasound Med; 2003 Nov; 22(11):1173-9. PubMed ID: 14620887
[TBL] [Abstract][Full Text] [Related]
5. Pretreatment and prospective assessment of endometrium in menopausal women taking tamoxifen for breast cancer.
Garuti G; Grossi F; Centinaio G; Sita G; Nalli G; Luerti M
Eur J Obstet Gynecol Reprod Biol; 2007 May; 132(1):101-6. PubMed ID: 16678960
[TBL] [Abstract][Full Text] [Related]
6. Endometrial thickness in tamoxifen-treated patients: correlation with clinical and pathologic findings.
Hann LE; Giess CS; Bach AM; Tao Y; Baum HJ; Barakat RR
AJR Am J Roentgenol; 1997 Mar; 168(3):657-61. PubMed ID: 9057510
[TBL] [Abstract][Full Text] [Related]
7. [Tamoxifen and endometrial pathology].
Negoiţă M; Terinte C; Mihailovici MS
Rev Med Chir Soc Med Nat Iasi; 2010; 114(4):1114-7. PubMed ID: 21500468
[TBL] [Abstract][Full Text] [Related]
8. Sonohysterography for evaluation of the endometrium in women treated with tamoxifen.
Hann LE; Gretz EM; Bach AM; Francis SM
AJR Am J Roentgenol; 2001 Aug; 177(2):337-42. PubMed ID: 11461858
[TBL] [Abstract][Full Text] [Related]
9. Prospective longitudinal study of ultrasound screening for endometrial abnormalities in women with breast cancer receiving tamoxifen.
Fung MF; Reid A; Faught W; Le T; Chenier C; Verma S; Brydon E; Fung KF
Gynecol Oncol; 2003 Oct; 91(1):154-9. PubMed ID: 14529676
[TBL] [Abstract][Full Text] [Related]
10. Prospective endometrial assessment of breast cancer patients treated with third generation aromatase inhibitors.
Garuti G; Cellani F; Centinaio G; Montanari G; Nalli G; Luerti M
Gynecol Oncol; 2006 Nov; 103(2):599-603. PubMed ID: 16750259
[TBL] [Abstract][Full Text] [Related]
11. Postmenopausal endometrial pathologies with tamoxifen treatment: comparison between hysteroscopic and hysterectomy findings.
Cohen I; Azaria R; Aviram R; Bernheim J; Tepper R; Cordoba M; Beyth Y
Gynecol Obstet Invest; 1999; 48(3):187-92. PubMed ID: 10545744
[TBL] [Abstract][Full Text] [Related]
12. Abnormalities detected on transvaginal ultrasonography in tamoxifen-treated postmenopausal breast cancer patients may represent endometrial cystic atrophy.
McGonigle KF; Shaw SL; Vasilev SA; Odom-Maryon T; Roy S; Simpson JF
Am J Obstet Gynecol; 1998 Jun; 178(6):1145-50. PubMed ID: 9662294
[TBL] [Abstract][Full Text] [Related]
13. Indication of hysteroscopy in tamoxifen treated breast cancer patients.
Taponeco F; Curcio C; Fasciani A; Giuntini A; Artini PG; Fornaciari G; Petraglia F; Genazzani AR
J Exp Clin Cancer Res; 2002 Mar; 21(1):37-43. PubMed ID: 12071527
[TBL] [Abstract][Full Text] [Related]
14. Uterine side effects of tamoxifen: a need for systematic pretreatment screening.
Berlière M; Charles A; Galant C; Donnez J
Obstet Gynecol; 1998 Jan; 91(1):40-4. PubMed ID: 9464718
[TBL] [Abstract][Full Text] [Related]
15. Uterine surveillance of asymptomatic postmenopausal women taking tamoxifen.
Gardner FJ; Konje JC; Brown L; Khanna S; Bell SC; Taylor DJ; al-Azzawi F
Climacteric; 1998 Sep; 1(3):180-7. PubMed ID: 11907942
[TBL] [Abstract][Full Text] [Related]
16. Endometrial pathology in postmenopausal tamoxifen treatment: comparison between gynaecologically symptomatic and asymptomatic breast cancer patients.
Cohen I; Perel E; Flex D; Tepper R; Altaras MM; Cordoba M; Beyth Y
J Clin Pathol; 1999 Apr; 52(4):278-82. PubMed ID: 10474520
[TBL] [Abstract][Full Text] [Related]
17. Diagnostic pitfalls of ultrasonographic uterine screening in women treated with tamoxifen.
Bornstein J; Auslender R; Pascal B; Gutterman E; Isakov D; Abramovici H
J Reprod Med; 1994 Sep; 39(9):674-8. PubMed ID: 7807477
[TBL] [Abstract][Full Text] [Related]
18. Hysteroscopically targeted biopsies compared with blind samplings in endometrial assessment of menopausal women taking tamoxifen for breast cancer.
Garuti G; Cellani F; Colonnelli M; Garzia D; Gonfiantini C; Luerti M
J Am Assoc Gynecol Laparosc; 2004 Feb; 11(1):62-7. PubMed ID: 15104834
[TBL] [Abstract][Full Text] [Related]
19. Postmenopausal tamoxifen treatment and endometrial pathology.
Cohen I; Altaras MM; Shapira J; Tepper R; Beyth Y
Obstet Gynecol Surv; 1994 Dec; 49(12):823-9. PubMed ID: 7885659
[TBL] [Abstract][Full Text] [Related]
20. [Uterine abnormalities in non menopausal women who received tamoxifen for breast cancer adjuvant therapy].
d'Arailh AS; Michy T; Pioud R; Dravet F; Classe JM
Gynecol Obstet Fertil; 2007 Dec; 35(12):1215-9. PubMed ID: 18035581
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
